Labianca R - Search Results

1

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Cascinu S, Poli D, Zaniboni A, Lonardi S, Labianca R, Sobrero A, Rosati G, Di Bartolomeo M, Scartozzi M, Zagonel V, Pella N, Banzi M, Torri V. Cascinu S, et al. Among authors: labianca r. Eur J Cancer. 2019 Apr;111:1-7. doi: 10.1016/j.ejca.2019.01.020. Epub 2019 Feb 21. Eur J Cancer. 2019. PMID: 30797014

2

Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente.

Zaniboni A, Labianca R, Pancera G, Barni S, Frontini L, Marini G, Luporini G. Zaniboni A, et al. Among authors: labianca r. J Chemother. 1995 Jun;7(3):246-8. doi: 10.1179/joc.1995.7.3.246. J Chemother. 1995. PMID: 7562022 Clinical Trial.

3

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

Lise M, Nitti D, Marchet A, Sahmoud T, Buyse M, Duez N, Fiorentino M, Dos Santos JG, Labianca R, Rougier P, et al. Lise M, et al. Among authors: labianca r. J Clin Oncol. 1995 Nov;13(11):2757-63. doi: 10.1200/JCO.1995.13.11.2757. J Clin Oncol. 1995. PMID: 7595735 Clinical Trial.

4

Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.

Labianca R, Giaccon G, Barni S, Ambrosini G, Iirillo A, Fiorentini G, Duro M, Piazza E, Oliani C, Pancera G, et al. Labianca R, et al. Eur J Cancer. 1994;30A(11):1611-6. doi: 10.1016/0959-8049(94)00190-g. Eur J Cancer. 1994. PMID: 7833131 Clinical Trial.

5

Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).

Labianca R, Pancera G, Barni S, Cascinu S, Comella G, Foa P, Martignoni G, Zaniboni A, Giaccon G, Luporini G. Labianca R, et al. Adv Exp Med Biol. 1993;339:233-7. Adv Exp Med Biol. 1993. PMID: 8178720 Review. No abstract available.

6

Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma.

Rosso R, Mazzei T, Sobrero A, Mini E, Cartei G, Conte P, Labianca R, Cartei F, Falcone A, Pancera G, et al. Rosso R, et al. Among authors: labianca r. Eur J Cancer. 1994;30A(3):338-43. doi: 10.1016/0959-8049(94)90253-4. Eur J Cancer. 1994. PMID: 8204356 Clinical Trial.

7

Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Lise M, Nitti D, Marchet A, Sahmoud T, Duez N, Fornasiero A, dos Santos JG, Labianca R, Lasser P, Gignoux M. Lise M, et al. Among authors: labianca r. Ann Surg Oncol. 1995 Nov;2(6):495-501. doi: 10.1007/BF02307082. Ann Surg Oncol. 1995. PMID: 8591079 Clinical Trial.

8

Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report.

Zaniboni A, Barni S, Labianca R, Marini G, Pancera G, Giaccon G, Piazza E, Signaroldi A, Legnani W, Luporini G. Zaniboni A, et al. Among authors: labianca r. Cancer. 1995 Nov 15;76(10):1694-9. doi: 10.1002/1097-0142(19951115)76:10<1694::aid-cncr2820761004>3.0.co;2-k. Cancer. 1995. PMID: 8625036 Clinical Trial.

9

Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD study.

Zaniboni A, Labianca R, Martignoni G, Barni S, Vinci M, Vaghi M, Pirovano M, Facendola G, Marini G, Luporini G. Zaniboni A, et al. Among authors: labianca r. J Chemother. 1996 Feb;8(1):82-4. doi: 10.1179/joc.1996.8.1.82. J Chemother. 1996. PMID: 8835115 Clinical Trial.

10

High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.

Labianca R, Cascinu S, Frontini L, Barni S, Fiorentini G, Comella G, Zaniboni A, Gottardi O, Arnoldi E, Oliani C, Duro M, Pavanato G, Martignoni G, Raina A, Piazza E, Dallavalle G, Valsecchi R, Pancera G, Luporini G. Labianca R, et al. Ann Oncol. 1997 Feb;8(2):169-74. doi: 10.1023/a:1008200713533. Ann Oncol. 1997. PMID: 9093726 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page